The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
NCT00983034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70
Last updated 2009-09-23
Summary
Membranous nephropathy (MN) may also be secondary to many other diseases (e.g., infections, drugs, neoplasms and autoimmune diseases). In this study, the presence of Helicobacter Pylori (H. pylori) antigen was investigated in renal tissue from needle biopsy samples, and the prevalence of H. pylori infection and the effects of H. pylori eradication on proteinuria level in patients with MN will be investigated.
Conditions
- Nephrotic Syndrome
- Glomerulonephritis
- Membranous Nephropathy
Interventions
- DRUG
-
lansoprazole, amoxicillin, clarithromycin
lansoprazole, 30 mg twice daily, plus amoxicillin, 0.75 g twice daily, plus clarithromycin, 250 mg twice daily, for 14 days
Sponsors & Collaborators
-
Istanbul University
lead OTHER
Principal Investigators
-
Yasar Caliskan, MD · Division of Nephrology, Istanbul Faculty of Medicine, Istanbul University
-
Berna Yelken, MD · Division of Nephrology, Istanbul Faculty of Medicine, Istanbul University
-
Halil Yazici, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University
-
Mehmet S Sever, Prof MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-03-31
- Primary Completion
- 2008-12-31
- Completion
- 2009-07-31
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Effect of PPI Therapy on the Result of Helicobacter Pylori Diagnostic Tests
NCT01278901 ·Status: UNKNOWN
-
Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms
NCT00772837 ·Status: COMPLETED ·Phase: NA
-
Comparison of Different Helicobacter Pylori Detection Methods in Patients With Chronic Atrophic Gastritis
NCT04923113 ·Status: COMPLETED ·Phase: NA
-
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
NCT01249482 ·Status: UNKNOWN
-
The Effact of Helicobacter Hylori Eradication on the Development of Gastric Mucosa Pathology
NCT04029441 ·Status: UNKNOWN
-
A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
NCT02806674 ·Status: UNKNOWN ·Phase: NA
-
Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients
NCT05927766 ·Status: UNKNOWN ·Phase: NA
-
Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy
NCT05790525 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation on Diagnosis and Treatment of Helicobacter Pylori Infection by Gastroenterologists in Shandong Province
NCT04918134 ·Status: COMPLETED
-
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
NCT02047994 ·Status: RECRUITING ·Phase: PHASE4
-
Role of Helicobacter Pylori in Microalbuminuria
NCT04216654 ·Status: COMPLETED
-
Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study
NCT02675010 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori and Dry Eye
NCT00083291 ·Status: COMPLETED
-
H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection
NCT00926809 ·Status: UNKNOWN ·Phase: PHASE4
-
Rapid Urease Test for Helicobacter Pylori in Population Who Stop Proton Pump Inhibitor Less Than 2 Weeks Compared With Histology
NCT04233684 ·Status: COMPLETED ·Phase: NA
-
Helicobacter Pylori and Proton Pump Inhibitor
NCT02449941 ·Status: COMPLETED
-
Standardize Communication With General Practitioner & Patient for Improved Eradication of Helicobacter Pylori
NCT02873247 ·Status: COMPLETED
-
Sensitivity and Specificity of the Modified Helicobacter Test INFAI
NCT04294823 ·Status: WITHDRAWN
-
Effect of Hp Infection on the Quality of Gastric Mucosa Preparation
NCT05527496 ·Status: UNKNOWN
-
A Study Reviewing Medical Records of Adults With Helicobacter Pylori Infections in China
NCT05073367 ·Status: COMPLETED
-
Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy
NCT05444439 ·Status: COMPLETED ·Phase: NA
-
Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
NCT06422052 ·Status: RECRUITING
-
Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex
NCT06371001 ·Status: NOT_YET_RECRUITING
-
Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.
NCT07306988 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy
NCT07293234 ·Status: NOT_YET_RECRUITING ·Phase: NA